Cogent Biosciences reported new 48 week data from its SUMMIT trial of bezuclastinib in NonAdvanced Systemic Mastocytosis. The results showed durable and significant improvement in symptoms and key ...
Approved Nasal Spray Loop Diuretic for Edema Associated with Congestive Heart Failure, Expected to Leverage Esperion’s Established Cardiovascular Commercial Infrastructure, Synergistically Expand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results